<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cach" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cach</book-part-id>
      <title-group>
        <title>Childhood Ataxia with Central Nervous System Hypomyelination/Vanishing White Matter</title>
        <alt-title alt-title-type="alt-title">Synonyms: Leukoencephalopathy with Vanishing White Matter, CACH/VWM</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schiffmann</surname>
            <given-names>Raphael</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Institute of Metabolic Disease<break/>Baylor Research Institute<break/>Dallas, Texas</aff>
          <email>raphael.schiffmann@baylorhealth.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fogli</surname>
            <given-names>Anne</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Genetics, Reproduction, and Development Unit<break/>Faculty of Medicine<break/>UMR INSERM 1103 CNRS 6293<break/>Clermont-Ferrand, France</aff>
          <email>anne.fogli@inserm.u-clermont1.fr</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>van der Knaap</surname>
            <given-names>Marjo S</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Child Neurology<break/>VU University Medical Center<break/>Amsterdam, The Netherlands</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Boespflug-Tanguy</surname>
            <given-names>Odile</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Reference Center for Leukodystrophies<break/>Department of Child Neurology<break/>Robert Debr&#x000e9; University Hospital<break/>University Paris Diderot- Sorbonne Cit&#x000e9;<break/>UMR INSERM 676<break/>Paris, France</aff>
          <email>odile.boespflug-tanguy@rdb.aphp.fr</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>20</day>
          <month>2</month>
          <year>2003</year>
        </date>
        <date date-type="updated">
          <day>24</day>
          <month>5</month>
          <year>2012</year>
        </date>
        <date date-type="revised">
          <day>9</day>
          <month>8</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cherubism" document-type="chapter">Cherubism</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cdp1-xlr" document-type="chapter">Chondrodysplasia Punctata 1, X-Linked</related-object>
      <abstract id="cach.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Childhood ataxia with central nervous system hypomyelination/vanishing white matter disease (CACH/VWM) is characterized by ataxia, spasticity, and variable optic atrophy. The phenotypic range includes a prenatal/congenital form, a subacute infantile form (onset age &#x0003c;1 year), an early childhood onset form (onset age 1-5 years), a late childhood /juvenile onset form (onset age 5-15 years), and an adult onset form. The prenatal/congenital form is characterized by severe encephalopathy. In the later onset forms initial motor and intellectual development is normal or mildly delayed followed by neurologic deterioration with a chronic progressive or subacute course. Chronic progressive decline can be exacerbated by rapid deterioration during febrile illnesses or following head trauma or major surgical procedures, or by acute psychological stresses such as extreme fright.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of CACH/VWM can be made with confidence in individuals with typical clinical findings, characteristic abnormalities on cranial MRI, and identifiable pathogenic variants in one of five genes (<italic toggle="yes">EIF2B1</italic>, <italic toggle="yes">EIF2B2</italic>, <italic toggle="yes">EIF2B3</italic>, <italic toggle="yes">EIF2B4</italic>, <italic toggle="yes">EIF2B5</italic>), encoding the five subunits of the eukaryotic translation initiation factor 2B (eIF2B). Pathogenic variants have been found in approximately 90% of individuals with CACH/VWM using sequence analysis or scanning.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Physical therapy and rehabilitation for motor dysfunction (mainly spasticity and ataxia); antiepileptic drugs for seizures.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Prevention of infections and fever when possible through the use of vaccinations, low-dose maintenance antibiotics during winter, antibiotics for minor infections, and antipyretics for fever. For children, wearing a helmet outside helps minimize the effects of head trauma.</p>
          <p><italic toggle="yes">Surveillance</italic>: Close monitoring of neurologic status for several days following head trauma or surgical procedures with anesthesia.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Contact sports, head trauma, stressful situations including high body temperature.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>CACH/VWM is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once an at-risk sib is known to be unaffected, the chance of his/her being a carrier is 2/3. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variants in an affected relative have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cach.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cach.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of childhood ataxia with central nervous system hypomyelination/leukoencephalopathy with vanishing white matter (CACH/VWM) can be made with confidence in individuals with typical clinical findings, characteristic abnormalities on cranial MRI [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.2006.413">van der Knaap et al 2006</xref>], and identifiable pathogenic variants in one of the five genes in which mutation is causative (<italic toggle="yes">EIF2B1</italic>, <italic toggle="yes">EIF2B2</italic>, <italic toggle="yes">EIF2B3</italic>, <italic toggle="yes">EIF2B4</italic>, <italic toggle="yes">EIF2B5</italic>), encoding the five subunits of the eukaryotic translation initiation factor 2B (eIF2B) [<xref ref-type="bibr" rid="cach.REF.leegwater.2001.383">Leegwater et al 2001</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_knaap.2002.264">van der Knaap et al 2002</xref>].</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Antenatal/early-infantile forms are characterized by severe encephalopathy; oligohydramnios, intrauterine growth retardation, microcephaly, contractures, cataract, pancreatitis, hepatosplenomegaly, and renal hypoplasia may be present.</p>
            </list-item>
            <list-item>
              <p>In all later onset forms initial motor and intellectual development is normal or mildly delayed.</p>
            </list-item>
            <list-item>
              <p>Neurologic deterioration has a chronic progressive or subacute course. Episodes of subacute deterioration may follow minor infection or minor head trauma and may lead to lethargy or coma.</p>
            </list-item>
            <list-item>
              <p>Clinical examination usually shows a combination of truncal and appendicular ataxia and spasticity with increased tendon reflexes. The peripheral nervous system is usually not involved.</p>
            </list-item>
            <list-item>
              <p>Optic atrophy may develop.</p>
            </list-item>
            <list-item>
              <p>Epilepsy may occur but is not the predominant sign of the disease except in an acute situation.</p>
            </list-item>
            <list-item>
              <p>Intellectual abilities may be affected but not to the same degree as motor functions. Alteration in intellectual abilities associated with behavioral changes can be the initial symptom in adult onset forms.</p>
            </list-item>
            <list-item>
              <p>Ovarian dysgenesis may be present as primary or secondary amenorrhea [<xref ref-type="bibr" rid="cach.REF.fogli.2003.1544">Fogli et al 2003</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>MRI findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The cerebral hemispheric white matter is symmetrically and diffusely abnormal.</p>
            </list-item>
            <list-item>
              <p>The abnormal white matter has a signal intensity close to or the same as cerebrospinal fluid (CSF) on T<sub>1</sub>-weighted (<xref ref-type="fig" rid="cach.Fa">Figure 1</xref>), T<sub>2</sub>-weighted (<xref ref-type="fig" rid="cach.Fa">Figure 2</xref>), and fluid-attenuated inversion recovery (FLAIR) (<xref ref-type="fig" rid="cach.Fa">Figure 3</xref>) images.</p>
            </list-item>
            <list-item>
              <p>On T<sub>1</sub>-weighted and FLAIR images, a fine meshwork of remaining tissue strands is usually visible within the areas of CSF-like white matter, with a typical radiating appearance on sagittal and coronal images and a dot-like pattern in the centrum semiovale on the transverse images (<xref ref-type="fig" rid="cach.F4">Figure 4</xref>) [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.2002.264">van der Knaap et al 2002</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_knaap.2006.413">van der Knaap et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>The MRI abnormalities are present in all affected individuals regardless of age of onset and are even present in asymptomatic at-risk sibs of a proband. Over time, increasing amounts of white matter vanish and are replaced with CSF; cystic breakdown of the white matter is seen on proton density or FLAIR images [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.2006.413">van der Knaap et al 2006</xref>]. Cerebellar atrophy varies from mild to severe and primarily involves the vermis.</p>
            </list-item>
            <list-item>
              <p>Supratentorial cortico-subcortical atrophy can be observed in adult onset forms with slow progression. Cranial CT scan is of limited use and usually shows diffuse and symmetric hypodensity of the cerebral hemispheric white matter with no calcifications.</p>
            </list-item>
          </list>
        </sec>
        <sec id="cach.Testing">
          <title>Testing</title>
          <p><bold>Routine laboratory tests,</bold> including CSF analysis, are normal.</p>
          <p>
            <bold>Research testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Eukaryotic translation initiation factor 2B (eIF2B) guanine exchange factor (GEF) activity</bold> measured in lymphoblastoid cell lines from affected individuals was found to be lower in most persons with pathogenic variants in <italic toggle="yes">EIF2B1</italic> through <italic toggle="yes">EIF2B</italic>5 than in control subjects [<xref ref-type="bibr" rid="cach.REF.fogli.2004b.561">Fogli et al 2004b</xref>]. eIF2B GEF activity assays in lymphoblastoid cell lines from 63 affected persons presenting with different clinical forms and <italic toggle="yes">EIF2B</italic> pathogenic variants showed a significantly decreased GEF activity in cells from <italic toggle="yes">EIF2B</italic> mutated individuals with 100% specificity and 89% sensitivity when the activity threshold was set at 77.5% of normal [<xref ref-type="bibr" rid="cach.REF.horzinski.2009.e8318">Horzinski et al 2009</xref>]. In the early infantile form of the disease (onset age &#x0003c;3 years) the GEF activity was below the threshold of 77.5% of normal. Persons with late onset disease and a wide variety of pathogenic variants (<xref ref-type="table" rid="cach.T.summary_of_molecular_genetic_test">Table 1</xref>) had higher GEF activity that overlapped with the normal range. A significant decrease of GEF activity has also been reported in the 8/8 <italic toggle="yes">EIF2B</italic> -mutated lymphoblastoid cell lines and 3/4 fibroblast cell lines analyzed by <xref ref-type="bibr" rid="cach.REF.liu.2011.1036">Liu et al [2011]</xref>. However, no correlation between eIF2B GEF activity and disease severity was found in this study. The findings were substantiated by similar results in transfected HEK293 cells [<xref ref-type="bibr" rid="cach.REF.liu.2011.1036">Liu et al 2011</xref>]. Thus it can be concluded that if decreased activity is found, CACH/VWM is the most likely diagnosis; but if normal or increased activity is found, CACH/VWM cannot be ruled out.</p>
            </list-item>
            <list-item>
              <p><bold>The CSF asialotransferrin/total transferrin ratio</bold> was found to be low in persons with genetically confirmed CACH/VWM, a finding that can help identify those likely to have pathogenic variants in any of the five genes encoding the eIF2B subunits detected on sequence analysis. Note: This test is cumbersome and may not be generally available.</p>
            </list-item>
          </list>
          <sec id="cach.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> The five genes (<italic toggle="yes">EIF2B1</italic>, <italic toggle="yes">EIF2B2</italic>, <italic toggle="yes">EIF2B3</italic>, <italic toggle="yes">EIF2B4</italic>, <italic toggle="yes">EIF2B5</italic>) that encode the five subunits of the eukaryotic translation initiation factor eIF2B are the genes in which pathogenic variants are known to cause CACH/VWM. In an affected individual both alleles are mutated in any one of the involved genes.</p>
            <p><bold>Evidence for locus heterogeneity.</bold> Approximately 10% of families with CACH/VWM diagnosed by MRI and clinical criteria do not have an identifiable pathogenic variant on sequence analysis of <italic toggle="yes">EIF2B1</italic>- <italic toggle="yes">EIF2B</italic>5, suggesting the possibility of causative pathogenic variants in other genes.</p>
            <table-wrap id="cach.T.summary_of_molecular_genetic_test" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Childhood Ataxia with Central Nervous System Hypomyelination/Vanishing White Matter</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Proportion of CACH/VWM Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pathogenic Variants Detected&#x000a0;<sup>3</sup></th>
                    <th id="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Gene and Test Method&#x000a0;<sup>4</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">EIF2B1</italic>
                    </td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">2%</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">See footnotes 2, 6</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>8</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">EIF2B2</italic>
                    </td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">13.6%</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">See footnotes 2, 6</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>8</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">EIF2B3</italic>
                    </td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">9.1%</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">See footnotes 2, 6</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>8</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">EIF2B4</italic>
                    </td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">10.6%</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">See footnotes 2, 6</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>8</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">EIF2B5</italic>
                    </td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">64.7%</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">See footnotes 2, 6</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>8</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted mutation analysis</td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="table" rid="cach.T.selected_eif2b5_pathogenic_varian">c.338G&#x0003e;A</xref>, <xref ref-type="table" rid="cach.T.selected_eif2b5_pathogenic_varian">c.584G&#x0003e;A</xref></td>
                    <td headers="hd_h_cach.T.summary_of_molecular_genetic_test_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">100% for the targeted variants&#x000a0;<sup>9</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="cach.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="shortname" object-id="shortname.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein name.</p>
                </fn>
                <fn id="cach.TF.1.2">
                  <label>2. </label>
                  <p>In individuals with MRI-confirmed CACH/VWM, mutation detection frequency for all five genes together is ~90% by sequence analysis/variant scanning [<xref ref-type="bibr" rid="cach.REF.leegwater.2001.383">Leegwater et al 2001</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_knaap.2002.264">van der Knaap et al 2002</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_knaap.2003.1199">van der Knaap et al 2003</xref>, <xref ref-type="bibr" rid="cach.REF.fogli.2004a.1509">Fogli et al 2004a</xref>, <xref ref-type="bibr" rid="cach.REF.ohtake.2004.1601">Ohtake et al 2004</xref>, <xref ref-type="bibr" rid="cach.REF.ohlenbusch.2005.411">Ohlenbusch et al 2005</xref>, <xref ref-type="bibr" rid="cach.REF.vermeulen.2005.560">Vermeulen et al 2005</xref>, <xref ref-type="bibr" rid="cach.REF.federico.2006.353">Federico et al 2006</xref>, <xref ref-type="bibr" rid="cach.REF.fogli.2006.22">Fogli &#x00026; Boespflug-Tanguy 2006</xref>, <xref ref-type="bibr" rid="cach.REF.kaczorowska.2006.192">Kaczorowska et al 2006</xref>, <xref ref-type="bibr" rid="cach.REF.mierzewska.2006.144">Mierzewska et al 2006</xref>, <xref ref-type="bibr" rid="cach.REF.pronk.2006.123">Pronk et al 2006</xref>, <xref ref-type="bibr" rid="cach.REF.ramaswamy.2006.65">Ramaswamy et al 2006</xref>, <xref ref-type="bibr" rid="cach.REF.scali.2006.271">Scali et al 2006</xref>, <xref ref-type="bibr" rid="cach.REF.denier.2007.1538">Denier et al 2007</xref>, <xref ref-type="bibr" rid="cach.REF.huntsman.2007.766">Huntsman et al 2007</xref>, <xref ref-type="bibr" rid="cach.REF.matsui.2007.57">Matsui et al 2007</xref>, <xref ref-type="bibr" rid="cach.REF.passemard.2007.400">Passemard et al 2007</xref>, <xref ref-type="bibr" rid="cach.REF.riecker.2007.544">Riecker et al 2007</xref>, <xref ref-type="bibr" rid="cach.REF.damonperriere.2008.1068">Damon-Perriere et al 2008</xref>, <xref ref-type="bibr" rid="cach.REF.fontenelle.2008.549">Fontenelle et al 2008</xref>, <xref ref-type="bibr" rid="cach.REF.horzinski.2008.410">Horzinski et al 2008</xref>, <xref ref-type="bibr" rid="cach.REF.jansen.2008.910">Jansen et al 2008</xref>, <xref ref-type="bibr" rid="cach.REF.maletkovic.2008.205">Maletkovic et al 2008</xref>, <xref ref-type="bibr" rid="cach.REF.mathis.2008.1035">Mathis et al 2008</xref>, <xref ref-type="bibr" rid="cach.REF.peter.2008.94">Peter et al 2008</xref>, <xref ref-type="bibr" rid="cach.REF.pineda.2008.29">Pineda et al 2008</xref>, <xref ref-type="bibr" rid="cach.REF.labauge.2009.2161">Labauge et al 2009</xref>, <xref ref-type="bibr" rid="cach.REF.wu.2009.74">Wu et al 2009</xref>].</p>
                </fn>
                <fn id="cach.TF.1.3">
                  <label>3. </label>
                  <p>See <xref ref-type="sec" rid="cach.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="cach.TF.1.4">
                  <label>4. </label>
                  <p>The ability of the test method used to detect a pathogenic variant that is present in the indicated gene</p>
                </fn>
                <fn id="cach.TF.1.5">
                  <label>5. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="cach.TF.1.6">
                  <label>6. </label>
                  <p>Approximately 90% of pathogenic variants are missense [<xref ref-type="bibr" rid="cach.REF.fogli.2004a.1509">Fogli et al 2004a</xref>]. Affected individuals are homozygotes or compound heterozygotes for pathogenic variants within the same gene. Pathogenic variants have been found in affected individuals of all ethnic origins [<xref ref-type="bibr" rid="cach.REF.leegwater.2001.383">Leegwater et al 2001</xref>, <xref ref-type="bibr" rid="cach.REF.fogli.2002b.506">Fogli et al 2002b</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_knaap.2002.264">van der Knaap et al 2002</xref>, <xref ref-type="bibr" rid="cach.REF.fogli.2004a.1509">Fogli et al 2004a</xref>].</p>
                </fn>
                <fn id="cach.TF.1.7">
                  <label>7. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="cach.TF.1.8">
                  <label>8. </label>
                  <p>No deletions or duplications involving <italic toggle="yes">EIF2B1</italic>, <italic toggle="yes">EIF2B2</italic>, <italic toggle="yes">EIF2B3</italic>, <italic toggle="yes">EIF2B4</italic>, or <italic toggle="yes">EIF2B5</italic> have been reported as causative of CACH/VWM. Therefore, the variant detection rate is unknown and may be very low.</p>
                </fn>
                <fn id="cach.TF.1.9">
                  <label>9. </label>
                  <p>Targeted pathogenic variants may vary by laboratory.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="cach.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>
                <bold>Single-gene testing</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Molecular genetic testing (in order) of <italic toggle="yes">EIF2B5</italic>, <italic toggle="yes">EIF2B2</italic>, <italic toggle="yes">EIF2B4</italic>, <italic toggle="yes">EIFB3</italic>, and <italic toggle="yes">EIF2B1</italic> is recommended. Sequencing of the coding sequence and associated splice sites must be performed.</p>
                </list-item>
                <list-item>
                  <p>Deletion/duplication analysis would also be useful to perform particularly in individuals with clinical CACH/VWM in whom direct sequencing has failed to identify pathogenic variants.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Multi-gene panel.</bold> Another strategy for molecular diagnosis of a proband suspected of having CACH/VWM is use of a multi-gene panel. Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time; a panel may not include a specific gene of interest.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p>
        </sec>
      </sec>
      <sec id="cach.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="cach.Clinical_Description">
          <title>Clinical Description</title>
          <p>Childhood ataxia with central nervous system hypomyelination/vanishing white matter disease (CACH/VWM) phenotypes range from a congenital or early infantile form to a subacute infantile form (onset age &#x0003c;1 year), an early childhood onset form (onset age 1-5 years), a late childhood/juvenile onset form (onset age 5-15 years), and an adult onset form [<xref ref-type="bibr" rid="cach.REF.fogli.2006.22">Fogli &#x00026; Boespflug-Tanguy 2006</xref>]. Both the childhood and juvenile forms have been observed in sibs [<xref ref-type="bibr" rid="cach.REF.leegwater.2001.383">Leegwater et al 2001</xref>]; the infantile and juvenile/adult forms have never been observed within the same family.</p>
          <p><bold>Neurology.</bold> The neurologic signs include ataxia, spasticity, and variable optic atrophy. In the early onset forms, the encephalopathy is severe, seizures are often a predominant clinical feature and decline is rapid and followed quickly by death; in the later onset forms, decline is usually slower and milder [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.2002.264">van der Knaap et al 2002</xref>]. Chronic progressive decline can be exacerbated by rapid deterioration during febrile illness or following minor head trauma or fright [<xref ref-type="bibr" rid="cach.REF.vermeulen.2005.560">Vermeulen et al 2005</xref>, <xref ref-type="bibr" rid="cach.REF.kaczorowska.2006.192">Kaczorowska et al 2006</xref>].</p>
          <p><bold>Ovarian failure.</bold> While the juvenile and adult forms are often associated with primary or secondary ovarian failure, a syndrome referred to as "ovarioleukodystrophy" [<xref ref-type="bibr" rid="cach.REF.schiffmann.1997.654">Schiffmann et al 1997</xref>, <xref ref-type="bibr" rid="cach.REF.fogli.2003.1544">Fogli et al 2003</xref>], ovarian dysgenesis may occur in any of the forms regardless of age of onset [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.2003.1199">van der Knaap et al 2003</xref>]; it has been found at autopsy in infantile and childhood cases. Because the affected individuals were prepubertal, the ovarian dysgenesis was clinically not manifest.</p>
          <p><bold>Antenatal form.</bold> The antenatal onset form presents in the third trimester of pregnancy with oligohydramnios and decreased fetal movement [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.2003.1199">van der Knaap et al 2003</xref>]. Clinical features that may be noted soon after birth include feeding difficulties, vomiting, hypotonia, mild contractures, and cataract (sometimes oil droplet cataract) and microcephaly. Apathy, intractable seizures, and finally apneic spells and coma follow. Other organ involvement can include hepatosplenomegaly, renal hypoplasia, pancreatitis, and ovarian dysgenesis.</p>
          <p>The clinical course is rapidly and relentlessly downhill; the adverse effect of stress factors is less clear. So far, all infants with neonatal presentation have died within the first year of life [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.2003.1199">van der Knaap et al 2003</xref>].</p>
          <p><bold>Infantile form.</bold> A rapidly fatal severe form of CACH/VWM is characterized by onset in the first year of life and death a few months later [<xref ref-type="bibr" rid="cach.REF.francalanci.2001.265">Francalanci et al 2001</xref>, <xref ref-type="bibr" rid="cach.REF.fogli.2002a.1966">Fogli et al 2002a</xref>, <xref ref-type="bibr" rid="cach.REF.fogli.2002b.506">Fogli et al 2002b</xref>]. Two sisters described by <xref ref-type="bibr" rid="cach.REF.francalanci.2001.265">Francalanci et al [2001]</xref> developed irritability, stupor, and rapid loss of motor abilities following an intercurrent infection at age ten to 11 months and died at age 21 months.</p>
          <p>Another infantile-onset phenotype was described as "Cree leukoencephalopathy" because of its occurrence in the native North American Cree and Chippewayan indigenous population [<xref ref-type="bibr" rid="cach.REF.fogli.2002b.506">Fogli et al 2002b</xref>]. Infants typically have hypotonia followed by sudden onset of seizures (age 3-6 months), spasticity, rapid breathing, vomiting (often with fever), developmental regression, blindness, lethargy, and cessation of head growth, with death by age two years.</p>
          <p><bold>Early childhood onset form.</bold> Initially most children develop normally; some have mild motor or speech delay. New-onset ataxia is the most common initial symptom between ages one and five years. Some children develop dysmetric tremor or become comatose spontaneously or acutely following mild head trauma or febrile illness [<xref ref-type="bibr" rid="cach.REF.schiffmann.1994.331">Schiffmann et al 1994</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_knaap.1997.845">van der Knaap et al 1997</xref>].</p>
          <p>Subsequently, generally progressive deterioration results in increasing difficulty in walking, tremor, spasticity with hyperreflexia, dysarthria, and seizures. Once a child becomes nonambulatory, the clinical course may remain stable for several years. Swallowing difficulties and optic atrophy develop late in the disease.</p>
          <p>Head circumference is usually normal; however, severe progressive megalencephaly occurring after age two years has been reported [<xref ref-type="bibr" rid="cach.REF.passemard.2007.400">Passemard et al 2007</xref>]; microcephaly has also been observed. The peripheral nervous system is usually normal, although predominantly sensory nerve involvement has been reported in recent cases [<xref ref-type="bibr" rid="cach.REF.federico.2006.353">Federico et al 2006</xref>, <xref ref-type="bibr" rid="cach.REF.huntsman.2007.766">Huntsman et al 2007</xref>]. Intellectual abilities are relatively preserved.</p>
          <p>The time course of disease progression varies from individual to individual even within the same family, ranging from rapid progression with death occurring one to five years after onset to very slow progression with death occurring many years after onset.</p>
          <p><bold>Late childhood/juvenile onset form.</bold> Children develop symptoms between ages five and 15 years. They often have a more slowly progressive spastic diplegia, relative sparing of cognitive ability, and likely long-term survival with long periods of stability and even improvement of motor function [<xref ref-type="bibr" rid="cach.REF.schiffmann.1994.331">Schiffmann et al 1994</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_knaap.1998.540">van der Knaap et al 1998</xref>]. However, rapid progression and death after a few months have also been described [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.1998.540">van der Knaap et al 1998</xref>].</p>
          <p><bold>Adult onset form.</bold> Behavioral problems associated with cognitive decline are frequently reported before neurologic symptoms appear [<xref ref-type="bibr" rid="cach.REF.labauge.2009.2161">Labauge et al 2009</xref>]. Acute, transient neurologic symptoms (optic neuritis, hemiparesis) or severe headache, as well as primary or secondary amenorrhea in females, can be the presenting symptoms.</p>
          <p>Asymptomatic and symptomatic adults with two pathogenic variants in one of the genes and a typically affected sib have also been described [<xref ref-type="bibr" rid="cach.REF.leegwater.2001.383">Leegwater et al 2001</xref>, <xref ref-type="bibr" rid="cach.REF.biancheri.2003.1818">Biancheri et al 2003</xref>, <xref ref-type="bibr" rid="cach.REF.ohtake.2004.1601">Ohtake et al 2004</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_knaap.2004.1598">van der Knaap et al 2004</xref>].</p>
          <p><bold>Neuropathologic findings</bold> in general are a "cavitating orthochromatic leukodystrophy with rarity of myelin breakdown and relative sparing of axons&#x0201d; [<xref ref-type="bibr" rid="cach.REF.fogli.2002b.506">Fogli et al 2002b</xref>]. Vacuolation and cavitation of the white matter are diffuse, giving a spongiform appearance. Cerebral and cerebellar myelin is markedly diminished, whereas the spinal cord is relatively spared. Oligodendrocytes are increased in number [<xref ref-type="bibr" rid="cach.REF.rodriguez.1999.469">Rodriguez et al 1999</xref>, <xref ref-type="bibr" rid="cach.REF.van_haren.2004.618">Van Haren et al 2004</xref>], whereas astrocytes are decreased, especially in the severe infantile form [<xref ref-type="bibr" rid="cach.REF.francalanci.2001.265">Francalanci et al 2001</xref>]. The hallmark is the presence of oligodendrocytes with "foamy" cytoplasm and markedly hypotrophic and sometimes atypical astrocytes [<xref ref-type="bibr" rid="cach.REF.wong.2000.635">Wong et al 2000</xref>]. The white matter astrocytes and oligodendrocytes are immature and are, in fact, astrocyte and oligodendrocyte precursor cells, explaining the lack of myelin production and scarce gliosis [<xref ref-type="bibr" rid="cach.REF.bugiani.2011.69">Bugiani et al 2011</xref>].</p>
        </sec>
        <sec id="cach.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Although intrafamilial variability exists, correlation between certain homozygous pathogenic variants and age of onset and disease severity has been described [<xref ref-type="bibr" rid="cach.REF.fogli.2004a.1509">Fogli et al 2004a</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_lei.2010.1555">van der Lei et al 2010</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>In individuals homozygous for the <xref ref-type="table" rid="cach.T.selected_eif2b5_pathogenic_varian">p.Thr91Ala</xref> pathogenic variant in <italic toggle="yes">EIF2B5</italic>, the phenotype may vary from childhood onset to adults with no symptoms [<xref ref-type="bibr" rid="cach.REF.leegwater.2001.383">Leegwater et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>The neonatal onset form is characterized by a more diffuse encephalopathy with failure of development and serious seizures [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.2003.1199">van der Knaap et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Certain <italic toggle="yes">EIF2B5</italic> homozygous pathogenic variants, such as <xref ref-type="table" rid="cach.T.selected_eif2b5_pathogenic_varian">p.Arg113His</xref>, never give rise to the infantile type [<xref ref-type="bibr" rid="cach.REF.fogli.2004a.1509">Fogli et al 2004a</xref>].</p>
            </list-item>
            <list-item>
              <p>Certain <italic toggle="yes">EIF2B5</italic> pathogenic variants, such as <xref ref-type="table" rid="cach.T.selected_eif2b5_pathogenic_varian">p.Val309Leu</xref>, are predictably associated with severe disease [<xref ref-type="bibr" rid="cach.REF.fogli.2004a.1509">Fogli et al 2004a</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="cach.Penetrance">
          <title>Penetrance</title>
          <p>Some adults who are homozygous or compound heterozygous for two disease-causing pathogenic variants in the same gene may be asymptomatic for prolonged periods of time [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.2004.1598">van der Knaap et al 2004</xref>].</p>
        </sec>
        <sec id="cach.Nomenclature">
          <title>Nomenclature</title>
          <p>"Cree leukoencephalopathy," described in the native North American Cree and Chippewayan indigenous population, is now recognized to be the same as the infantile form of CACH/VWM [<xref ref-type="bibr" rid="cach.REF.fogli.2002b.506">Fogli et al 2002b</xref>].</p>
        </sec>
        <sec id="cach.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of CACH/VWM is not known; it is considered one of the most common leukodystrophies. In a study of unclassified leukodystrophies in childhood, CACH/VWM was the most common [<xref ref-type="bibr" rid="cach.REF.van_der_knaap.1999.121">van der Knaap et al 1999</xref>].</p>
          <p>In some countries, the incidence of CACH/VWM is close to that of metachromatic leukodystrophy (see <related-object link-type="booklink" source-id="gene" document-id="mld" document-type="chapter">Arylsulfatase A Deficiency</related-object>) [van der Knaap, personal communication].</p>
        </sec>
      </sec>
      <sec id="cach.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Thus far, all individuals with eIF2B-related disease have a leukodystrophy; no other phenotypes have been observed.</p>
      </sec>
      <sec id="cach.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other disorders affecting the white matter diffusely during childhood to consider, with their distinguishing MRI findings:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="x-ald" document-type="chapter"><bold>X-linked adrenoleukodystrophy</bold></related-object><bold>,</bold>
<related-object link-type="booklink" source-id="gene" document-id="mld" document-type="chapter"><bold>metachromatic leukodystrophy</bold></related-object><bold>,</bold>
<related-object link-type="booklink" source-id="gene" document-id="krabbe" document-type="chapter"><bold>Krabbe disease</bold></related-object><bold>, and</bold>
<related-object link-type="booklink" source-id="gene" document-id="canavan" document-type="chapter"><bold>Canavan disease</bold></related-object><bold>.</bold> In the cerebral form of X-linked adrenoleukodystrophy and the other three disorders, MRI shows extensive or diffuse cerebral white matter changes but as a rule no cystic degeneration.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="alexander" document-type="chapter"><bold>Alexander disease</bold></related-object><bold>.</bold> In this condition white matter signal changes have a frontal predominance. The cystic degeneration may affect the subcortical or deep white matter. Basal ganglia and thalamic abnormalities are frequently present. Contrast enhancement of characteristic structures often facilitates the diagnosis. The diagnosis can be established with molecular genetic testing.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="mlc" document-type="chapter"><bold>Megalencephalic leukoencephalopathy with subcortical cysts</bold></related-object>
<bold>(MLC),</bold> characterized by diffusely abnormal and mildly swollen cerebral hemispheric white matter that does not show signs of diffuse rarefaction or cystic degeneration. Subcortical cysts are almost always present in the anterior temporal area and often in other regions. The cysts are best seen on proton density and FLAIR. The diagnosis can usually be established with molecular genetic testing.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter"><bold>Mitochondrial disorders</bold></related-object><bold>,</bold> including deficiencies of pyruvate dehydrogenase and <related-object link-type="booklink" source-id="gene" document-id="pdc" document-type="chapter">pyruvate carboxylase</related-object>. MRI abnormalities similar to those seen in CACH/VWM with prominent and diffuse white matter rarefaction and cystic degeneration may be seen in mitochondrial disorders [<xref ref-type="bibr" rid="cach.REF.de_lonlaydebeney.2000.209">de Lonlay-Debeney et al 2000</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="pmd" document-type="chapter"><bold><italic toggle="yes">PLP1-</italic>related disorders</bold></related-object>
<bold>(Pelizaeus Merzbacher disease and X-linked spastic paraplegia type 2).</bold> Diffuse hyperintensity of the white matter on T<sub>2</sub>-weighted images is also observed in leukodystrophies with primary hypomyelination, such as the <italic toggle="yes">PLP1</italic>-related disorders; however, these disorders have a normal or nearly normal white matter signal on T<sub>1</sub>-weighted images and CT scan. In addition, central nerve conduction evaluated with evoked potentials is always severely affected even at an early stage of the disease.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="cadasil" document-type="chapter"><bold>CADASIL</bold></related-object><bold>, lamin B1 pathogenic variants, or acquired white matter disorders such as multiple sclerosis</bold> need to be considered in individuals with adult-onset CACH/VWM; however, the early, constant, diffuse, symmetric alteration of the white matter on MRI in eIF2B-related disorders is distinctive.</p>
          </list-item>
        </list>
        <p>Further studies are needed to determine if white matter disorders described as orthochromatic leukodystrophies are related to CACH/VWM.</p>
      </sec>
      <sec id="cach.Management">
        <title>Management</title>
        <sec id="cach.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with childhood ataxia with central nervous system hypomyelination/vanishing white matter disease (CACH/VWM), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Brain MRI</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination</p>
            </list-item>
            <list-item>
              <p>Neurologic examination</p>
            </list-item>
            <list-item>
              <p>Physical therapy/occupational therapy assessment as needed</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="cach.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical therapy and rehabilitation for motor dysfunction (mainly spasticity and ataxia)</p>
            </list-item>
            <list-item>
              <p>Ankle-foot orthotics in individuals with hypotonia and weakness of ankle dorsiflexors</p>
            </list-item>
            <list-item>
              <p>Antiepileptic drugs for treatment of seizures and abnormalities of behavior and mood</p>
            </list-item>
          </list>
        </sec>
        <sec id="cach.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Considering the known adverse effect of fever, it is important to prevent infections and fever as much as possible (e.g., through the use of vaccinations, including anti-flu vaccination); low-dose maintenance antibiotics during winter time, antibiotics for minor infections, and antipyretics for fever are appropriate. For children, wearing a helmet outside helps minimize the effects of possible head trauma.</p>
        </sec>
        <sec id="cach.Surveillance">
          <title>Surveillance</title>
          <p>Close surveillance for several days following head trauma or major surgical procedure with anesthesia is indicated because neurologic deterioration (presumably stress related) may follow.</p>
        </sec>
        <sec id="cach.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Avoid the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Contact sports and other activities with a high risk of head trauma</p>
            </list-item>
            <list-item>
              <p>Stressful emotional and physical situations (e.g., extreme temperatures)</p>
            </list-item>
          </list>
        </sec>
        <sec id="cach.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="cach.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cach.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="cach.Other">
          <title>Other</title>
          <p>In general, corticosteriods and intravenous gamma globulin are not effective in the treatment of CACH/VWM. Corticosteriods have been used with inconsistent results in acute situations, including intractable status epilepticus.</p>
        </sec>
      </sec>
      <sec id="cach.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cach.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Childhood ataxia with central nervous system hypomyelination/vanishing white matter disease (CACH/VWM) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="cach.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore each carry a mutated allele.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic. No clinical or MRI abnormalities have been found in carriers of pathogenic variants in <italic toggle="yes">EIF2B1</italic>-<italic toggle="yes">EIF2B5</italic>.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Age of onset of neurologic signs can differ from one individual to another within the same family. Therefore, a neurologically asymptomatic sib of an affected individual may be homozygous for the pathogenic variant and at high risk of developing the disease. The large majority (if not all) of apparently asymptomatic individuals seem to have the diffuse white matter abnormalities characteristic of the syndrome on head MRI, and may have very mild learning, cognitive, or behavioral disabilities.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the chance of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic. No clinical or MRI abnormalities have been found in carriers of pathogenic variants in <italic toggle="yes">EIF2B1</italic>-<italic toggle="yes">EIF2B5</italic>.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with CACH/VWM are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">EIF2B1</italic>-<italic toggle="yes">EIF2B5</italic>.</p>
          <p><bold>Other family members of a proband.</bold> Sibs of the proband's parents are at increased risk of being carriers.</p>
        </sec>
        <sec id="cach.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible once the pathogenic variants have been identified in the proband.</p>
        </sec>
        <sec id="cach.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to parents of an affected individual and to young adults who are affected or at risk, or are carriers.</p>
            </list-item>
          </list>
          <p><bold>Testing of at-risk asymptomatic individuals.</bold> Testing of at-risk asymptomatic individuals for CACH/VWM is possible using the techniques described in <xref ref-type="sec" rid="cach.Molecular_Genetic_Testing">Molecular Genetic Testing</xref>. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. When testing at-risk individuals for CACH/VWM, an affected family member should be tested first to confirm the molecular diagnosis in the family.</p>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="cach.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the pathogenic variants have been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for CACH/VWM are possible.</p>
        </sec>
      </sec>
      <sec id="cach.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cach.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="cach.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The eukaryotic translation initiation factor eIF2B is composed of five subunits. Its function is to convert protein synthesis initiation factor 2 (eIF2) from an inactive GDP-bound form to an active eIF2-GTP complex, allowing the formation of the 43S complex, precursor of protein translation initiation. It is not yet understood why a defect in eIF2B, a ubiquitous protein complex, affects predominantly the brain white matter. The crucial role of eIF2B as regulator of protein synthesis under stress conditions could explain the neurologic deterioration during or after head trauma and fever [<xref ref-type="bibr" rid="cach.REF.leegwater.2001.383">Leegwater et al 2001</xref>].</p>
          <p>Yeast with null pathogenic variants for any of the five genes <italic toggle="yes">EIF2B1</italic>-<italic toggle="yes">EIF2B5</italic> are not viable. Pathogenic variants that completely abolish eIF2B activity are probably lethal in the homozygous state in humans; this explains why nonsense variants are rare and only observed in compound heterozygotes in association with a pathogenic missense variant [<xref ref-type="bibr" rid="cach.REF.leegwater.2001.383">Leegwater et al 2001</xref>, <xref ref-type="bibr" rid="cach.REF.fogli.2002b.506">Fogli et al 2002b</xref>, <xref ref-type="bibr" rid="cach.REF.van_der_knaap.2002.264">van der Knaap et al 2002</xref>]. Pathogenic variants in <italic toggle="yes">EIF2B1</italic>-<italic toggle="yes">EIF2B5</italic> were shown to decrease the guanine exchange factor (GEF) activity in vitro in yeast and mammalian cellular models. This reduction in activity results from aberrant protein folding, leading to an impaired ability to form functional eIF2B complexes that bind substrate normally [<xref ref-type="bibr" rid="cach.REF.li.2004.3295">Li et al 2004</xref>, <xref ref-type="bibr" rid="cach.REF.richardson.2004.2352">Richardson et al 2004</xref>, <xref ref-type="bibr" rid="cach.REF.van_kollenburg.2006a.496">van Kollenburg et al 2006a</xref>]. The decrease in GEF activity leads to enhanced translation of specific mRNA of proteins, similar to the situation that occurs when a cell is under stress. Decreased GEF activity of 20%-77% of normal was also found in lymphoblasts of most affected individuals but was normal in obligate heterozygotes [<xref ref-type="bibr" rid="cach.REF.fogli.2004b.561">Fogli et al 2004b</xref>, <xref ref-type="bibr" rid="cach.REF.horzinski.2009.e8318">Horzinski et al 2009</xref>] and some patients [<xref ref-type="bibr" rid="cach.REF.horzinski.2009.e8318">Horzinski et al 2009</xref>, <xref ref-type="bibr" rid="cach.REF.liu.2011.1036">Liu et al 2011</xref>]. Hyper-induction of ATF4-mediated ER-stress response is variably found in eIF2B-mutated cells [<xref ref-type="bibr" rid="cach.REF.kantor.2005.99">Kantor et al 2005</xref>, <xref ref-type="bibr" rid="cach.REF.kantor.2008.e3783">Kantor et al 2008</xref>, <xref ref-type="bibr" rid="cach.REF.horzinski.2010.94">Horzinski et al 2010</xref>] or brain [<xref ref-type="bibr" rid="cach.REF.van_der_voorn.2005.770">van der Voorn et al 2005</xref>, <xref ref-type="bibr" rid="cach.REF.van_kollenburg.2006b.707">van Kollenburg et al 2006b</xref>].</p>
          <p><bold>Gene structure.</bold> See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cach-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> (pdf) for exon number and cDNA length of each gene. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cach" object-id="cach.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cach-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf) for a listing and frequency of selected pathogenic variants of each gene.</p>
          <table-wrap id="cach.T.selected_eif2b5_pathogenic_varian" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Selected <italic toggle="yes">EIF2B5</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.271A&#x0003e;G</td>
                  <td headers="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr91Ala</td>
                  <td headers="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/83267878">NM_003907.2</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/83267879">NP_003898.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.338G&#x0003e;A</td>
                  <td headers="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg113His</td>
                </tr>
                <tr>
                  <td headers="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.584G&#x0003e;A</td>
                  <td headers="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg195His</td>
                </tr>
                <tr>
                  <td headers="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.925G&#x0003e;C</td>
                  <td headers="hd_h_cach.T.selected_eif2b5_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val309Leu</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cach-Table5.pdf" content-type="local-data">Table 5</inline-supplementary-material> (pdf) for a description of protein subunits.</p>
          <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="cach.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
        </sec>
      </sec>
      <sec id="cach.References">
        <title>References</title>
        <sec id="cach.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cach.Literature_Cited.reflist0">
            <ref id="cach.REF.biancheri.2003.1818">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biancheri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filocamo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tortori-Donati</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Leukoencephalopathy with vanishing white matter: an adult onset case.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>1818</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14694060</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.bugiani.2011.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bugiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boor</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kollenburg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Postma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kesteren</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Windrem</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hol</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Defective glial maturation in vanishing white matter disease.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>70</volume>
                <fpage>69</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">21157376</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.damonperriere.2008.1068">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Damon-Perriere</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menegon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anne</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creveaux</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dousset</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brochet</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease.</article-title>
                <source>Clin Neurol Neurosurg</source>
                <volume>110</volume>
                <fpage>1068</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">18845387</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.de_lonlaydebeney.2000.209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Lonlay-Debeney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Kleist-Retzow</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hertz-Pannier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peudenier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berquin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chretien</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baraton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunelle</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Cerebral white matter disease in children may be caused by mitochondrial respiratory chain deficiency.</article-title>
                <source>J Pediatr</source>
                <volume>136</volume>
                <fpage>209</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">10657827</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.denier.2007.1538">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orgibet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roffi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jouvent</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buhl</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducreux</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Adult-onset vanishing white matter leukoencephalopathy presenting as psychosis.</article-title>
                <source>Neurology</source>
                <volume>68</volume>
                <fpage>1538</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17470759</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.federico.2006.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scali</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stromillo</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Perri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sicurelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Stefano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malandrini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation.</article-title>
                <source>Neurology</source>
                <volume>67</volume>
                <fpage>353</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16864840</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.fogli.2006.22">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The large spectrum of eIF2B-related diseases.</article-title>
                <source>Biochem Soc Trans</source>
                <volume>34</volume>
                <fpage>22</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16246171</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.fogli.2002a.1966">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deodato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartuli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002a</year>
                <article-title>A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation.</article-title>
                <source>Neurology.</source>
                <volume>59</volume>
                <fpage>1966</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12499492</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.fogli.2003.1544">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard-Pierre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouhour</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labauge</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meaney</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeesman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Ovarian failure related to eukaryotic initiation factor 2B mutations.</article-title>
                <source>Am J Hum Genet</source>
                <volume>72</volume>
                <fpage>1544</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">12707859</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.fogli.2004a.1509">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ughetto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combes</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard-Pierre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pineda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troncoso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pugin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaunu</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>The effect of genotype on the natural history of eIF2B-related leukodystrophies.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>1509</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">15136673</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.fogli.2004b.561">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hugendubler</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combes</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimball</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>12</volume>
                <fpage>561</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15054402</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.fogli.2002b.506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard-Pierre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouffard</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.</article-title>
                <source>Ann Neurol</source>
                <volume>52</volume>
                <fpage>506</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">12325082</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.fontenelle.2008.549">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fontenelle</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brand&#x000e3;o</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Atypical presentation of vanishing white matter disease.</article-title>
                <source>Arq Neuropsiquiatr</source>
                <volume>66</volume>
                <fpage>549</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">18813718</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.francalanci.2001.265">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Francalanci</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard-Pierre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boldrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piemonte</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Virgili</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fariello</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Fatal infantile leukodystrophy: a severe variant of CACH/VWM syndrome, allelic to chromosome 3q27.</article-title>
                <source>Neurology</source>
                <volume>57</volume>
                <fpage>265</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">11468311</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.horzinski.2008.410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horzinski</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonthier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Exon deletion in the non catalytic domain of eIF2B&#x003b5; due to a splice site mutation leads to infantile forms of CACH/VWM with severe decrease of eIF2B GEF activity.</article-title>
                <source>Ann Hum Genet.</source>
                <volume>72</volume>
                <fpage>410</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">18294360</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.horzinski.2009.e8318">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horzinski</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huyghe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardoso</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonthier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouchchane</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanc</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.</article-title>
                <source>PLoS One.</source>
                <year>2009</year>
                <volume>4</volume>
                <fpage>e8318</fpage>
                <pub-id pub-id-type="pmid">20016818</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.horzinski.2010.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horzinski</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kantor</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huyghe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elroy-Stein</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients.</article-title>
                <source>BMC Neurol.</source>
                <volume>10</volume>
                <fpage>94</fpage>
                <pub-id pub-id-type="pmid">20958979</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.huntsman.2007.766">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huntsman</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seshia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lowry</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemire</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harder</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Peripheral neuropathy in a child with Cree leukodystrophy.</article-title>
                <source>J Child Neurol</source>
                <volume>22</volume>
                <fpage>766</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17641267</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.jansen.2008.910">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creveaux</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Leucoencephalopathy with vanishing white mater may cause progressive myoclonus epilepsy.</article-title>
                <source>Epilepsia.</source>
                <volume>49</volume>
                <fpage>910</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18266750</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.kaczorowska.2006.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaczorowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuczynski</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkiewicz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jozwiak</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Acute fright induces onset of symptoms in vanishing white matter disease-case report.</article-title>
                <source>Eur J Paediatr Neurol</source>
                <volume>10</volume>
                <fpage>192</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16952472</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.kantor.2005.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kantor</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ron</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimball</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elroy-Stein</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.</article-title>
                <source>Hum Genet.</source>
                <year>2005</year>
                <volume>118</volume>
                <fpage>99</fpage>
                <lpage>106</lpage>
                <pub-id pub-id-type="pmid">16041584</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.kantor.2008.e3783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kantor</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinchasi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mintz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hathout</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elroy-Stein</surname>
                    <given-names>O.</given-names>
                  </name>
                </person-group>
                <article-title>A point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells.</article-title>
                <source>PLoS ONE.</source>
                <year>2008</year>
                <volume>3</volume>
                <fpage>e3783</fpage>
                <pub-id pub-id-type="pmid">19023445</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.labauge.2009.2161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Labauge</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horzinski</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayrignac</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanc</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vukusic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mauguiere</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouhour</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Confavreux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obadia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanc</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de S&#x000e8;ze</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.</article-title>
                <source>Brain</source>
                <volume>132</volume>
                <fpage>2161</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19625339</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.leegwater.2001.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leegwater</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konst</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulders</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Visser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kersbergen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mobach</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fonds</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemmers</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oudejans</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schutgens</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>383</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11704758</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.li.2004.3295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proud</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways.</article-title>
                <source>Mol Cell Biol</source>
                <volume>24</volume>
                <fpage>3295</fpage>
                <lpage>306</lpage>
                <pub-id pub-id-type="pmid">15060152</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.liu.2011.1036">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Lei</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wortham</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mufunde</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proud</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes.</article-title>
                <source>Hum Mutat.</source>
                <volume>32</volume>
                <fpage>1036</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">21560189</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.maletkovic.2008.205">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maletkovic</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorospe</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mintz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alper</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singhal</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amartino</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renaud</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senbil</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kadom</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nazarian</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morizono</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Genetic and clinical heterogeneity in eIF2B-related disorder.</article-title>
                <source>J Child Neurol.</source>
                <volume>23</volume>
                <fpage>205</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">18263758</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.mathis.2008.1035">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mathis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petit</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gil</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neau</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The ovarioleukodystrophy.</article-title>
                <source>Clin Neurol Neurosurg.</source>
                <volume>110</volume>
                <fpage>1035</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18678442</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.matsui.2007.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizutani</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohtake</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishizu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimohata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takayama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibasaki</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Novel mutation in EIF2B gene in a case of adult-onset leukoencephalopathy with vanishing white matter.</article-title>
                <source>Eur Neurol.</source>
                <volume>57</volume>
                <fpage>57</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17119336</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.mierzewska.2006.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mierzewska</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkiewicz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt-Sidor</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szymanska</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases.</article-title>
                <source>Folia Neuropathologica.</source>
                <volume>44</volume>
                <fpage>144</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16823698</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.ohlenbusch.2005.411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohlenbusch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henneke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goerg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlsch&#x000fc;tter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e4;rtner</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Identification of ten novel mutations in patients with eIF2B-related disorders.</article-title>
                <source>Hum Mutat.</source>
                <volume>25</volume>
                <fpage>411</fpage>
                <pub-id pub-id-type="pmid">15776425</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.ohtake.2004.1601">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohtake</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimohata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terajima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaseda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iizuka</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akaiwa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muratake</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosoki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shioiri</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Someya</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>1601</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15136690</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.passemard.2007.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Passemard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fogli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N'Guyen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnerias</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doummar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arbues</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Villemeur</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponsot</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families.</article-title>
                <source>Neurology</source>
                <volume>69</volume>
                <fpage>400</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">17646634</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.peter.2008.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catenoix</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demarquay</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petiot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudigoz</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryvlin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maugui&#x000e8;re</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor.</article-title>
                <source>Eur J Neurol.</source>
                <volume>15</volume>
                <fpage>94</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">18005052</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.pineda.2008.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pineda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmero</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baquero</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Callaghan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aracil</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Vanishing white matter disease associated with progressive macrocephaly.</article-title>
                <source>Neuropediatrics.</source>
                <volume>39</volume>
                <fpage>29</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">18504679</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.pronk.2006.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kollenburg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Vanishing white matter disease: a review with focus on its genetics.</article-title>
                <source>Ment Retard Dev Disabil Res Rev</source>
                <volume>12</volume>
                <fpage>123</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16807905</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.ramaswamy.2006.65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramaswamy</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolski</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Vanishing white matter disease with periodic (paroxysmal) hemiparesis.</article-title>
                <source>Pediatr Neurol</source>
                <volume>35</volume>
                <fpage>65</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16814090</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.richardson.2004.2352">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammad</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavitt</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity.</article-title>
                <source>Mol Cell Biol</source>
                <volume>24</volume>
                <fpage>2352</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">14993275</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.riecker.2007.544">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riecker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000e4;gele</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henneke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Late onset vanishing white matter disease.</article-title>
                <source>J Neurol</source>
                <volume>254</volume>
                <fpage>544</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17401526</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.rodriguez.1999.469">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>della Gaspera</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robain</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponsot</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarlieve</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghandour</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pompidou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dautigny</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aubourg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pham-Dinh</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>97</volume>
                <fpage>469</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">10334484</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.scali.2006.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scali</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Perri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The spectrum of mutations for the diagnosis of vanishing white matter disease.</article-title>
                <source>Neurol Sci</source>
                <volume>27</volume>
                <fpage>271</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16998732</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.schiffmann.1994.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trapp</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shih</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alger</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauer</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>1994</year>
                <article-title>Childhood ataxia with diffuse central nervous system hypomyelination.</article-title>
                <source>Ann Neurol</source>
                <volume>35</volume>
                <fpage>331</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">8122885</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.schiffmann.1997.654">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tedeschi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinkel</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trapp</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frank</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanovski</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Leukodystrophy in patients with ovarian dysgenesis.</article-title>
                <source>Ann Neurol</source>
                <volume>41</volume>
                <fpage>654</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">9153528</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_knaap.1997.845">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabreels</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franzoni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Begeer</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroink</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotteveel</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>A new leukoencephalopathy with vanishing white matter.</article-title>
                <source>Neurology</source>
                <volume>48</volume>
                <fpage>845</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">9109866</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_knaap.1998.540">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamphorst</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraaijeveld</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gut</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Phenotypic variation in leukoencephalopathy with vanishing white matter.</article-title>
                <source>Neurology</source>
                <volume>51</volume>
                <fpage>540</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9710032</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_knaap.2002.264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leegwater</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konst</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Visser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oudejans</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schutgens</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.</article-title>
                <source>Ann Neurol</source>
                <volume>51</volume>
                <fpage>264</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">11835386</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_knaap.2004.1598">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leegwater</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storey</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Arg113His mutation in eIF2Bepsilon as cause of leukoencephalopathy in adults.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>1598</fpage>
                <lpage>600</lpage>
                <pub-id pub-id-type="pmid">15136689</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_knaap.2006.413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Vanishing white matter disease.</article-title>
                <source>Lancet Neurol</source>
                <volume>5</volume>
                <fpage>413</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">16632312</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_knaap.2003.1199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herms</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Coster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baethmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boltshauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plecko</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proud</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>eIF2B-related disorders: antenatal onset and involvement of multiple organs.</article-title>
                <source>Am J Hum Genet</source>
                <volume>73</volume>
                <fpage>1199</fpage>
                <lpage>207</lpage>
                <pub-id pub-id-type="pmid">14566705</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_knaap.1999.121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breiter</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach.</article-title>
                <source>Radiology</source>
                <volume>213</volume>
                <fpage>121</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">10540652</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_lei.2010.1555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Lei</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Wieringen</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feigenbaum</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercimek-Mahmutoglu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippart</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatli</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wassmer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Genotype-phenotype correlation in vanishing white matter disease.</article-title>
                <source>Neurology</source>
                <volume>75</volume>
                <fpage>1555</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20975056</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_voorn.2005.770">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Voorn</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kollenburg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Haren</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powers</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>The unfolded protein response in vanishing white matter disease.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <year>2005</year>
                <volume>64</volume>
                <fpage>770</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16141786</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_haren.2004.618">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Haren</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Voorn</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powers</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The life and death of oligodendrocytes in vanishing white matter disease.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>63</volume>
                <fpage>618</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15217090</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_kollenburg.2006a.496">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Kollenburg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proud</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2006a</year>
                <article-title>Regulation of protein synthesis in lymphoblasts from vanishing white matter patients.</article-title>
                <source>Neurobiol Dis</source>
                <volume>21</volume>
                <fpage>496</fpage>
                <lpage>504</lpage>
                <pub-id pub-id-type="pmid">16185887</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_kollenburg.2006b.707">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Kollenburg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powers</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease.</article-title>
                <source>J Neuropathol Exp Neurol.</source>
                <year>2006b</year>
                <volume>65</volume>
                <fpage>707</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">16825957</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.vermeulen.2005.560">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidl</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercimek-Mahmutoglu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotteveel</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Fright is a provoking factor in vanishing white matter disease.</article-title>
                <source>Ann Neurol</source>
                <volume>57</volume>
                <fpage>560</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15786451</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.wong.2000.635">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gyure</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matalon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wollmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>TQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crutchfield</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>100</volume>
                <fpage>635</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">11078215</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.wu.2009.74">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease.</article-title>
                <source>J Hum Genet.</source>
                <volume>54</volume>
                <fpage>74</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19158808</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="cach.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="cach.Suggested_Reading.reflist0">
            <ref id="cach.REF.scheper.2006.159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proud</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Defective translation initiation causes vanishing of cerebral white matter.</article-title>
                <source>Trends Mol Med</source>
                <volume>12</volume>
                <fpage>159</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">16545608</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.schiffmann.2006.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elroy-Stein</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis.</article-title>
                <source>Mol Genet Metab</source>
                <volume>88</volume>
                <fpage>7</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">16378743</pub-id>
              </element-citation>
            </ref>
            <ref id="cach.REF.van_der_knaap">
              <mixed-citation publication-type="book">van der Knaap MS, Bugiani M, Boor I, Proud CG, Scheper GC. Vanishing white matter. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 235.1. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cach.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cach.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>9 August 2012 (cd) Revision: multi-gene panel for this disorder now listed in the GeneTests&#x02122; Laboratory Directory</p>
            </list-item>
            <list-item>
              <p>24 May 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 February 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>30 July 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 February 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>19 November 2002 (pb) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="cach.Fa" orientation="portrait">
          <caption>
            <p>MRI of an individual with the classic form of CACHFigure 1. Diffuse hypointensity of the white matter on T<sub>1</sub>-weighted images Figure 2. Increased signal intensity in the same white matter area on T<sub>2</sub>-weighted images Figure 3. Secondary cavitation in the abnormal white matter seen on both the T<sub>1</sub>-weighted and the FLAIR images. Note the absence of cortical atrophy and of dilation of the lateral ventricles.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cach-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="cach.F4" orientation="portrait">
          <label>Figure 4. </label>
          <caption>
            <p>Parasagittal T<sub>1</sub>-weighted MRI image of an individual with CACH shows diffuse hypointensity of the white matter interrupted by a typical meshwork of remaining tissue strands radiating across the abnormal white matter.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cach-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
